Sharps Technology’s $400M Solana Pivot: Healthcare Firm Bets on Web3 Treasury
🔑 Key Takeaways Sharps Technology (NASDAQ: STSS) raised $400M via PIPE financing to build a Solana-native corporate treasury , marking a dramatic pivot from its medical device roots. Backers include Pantera Capital, ParaFi, FalconX, CoinFund, and Arrington Capital , signaling serious institutional validation. A Letter of Intent (LOI) with Solana Foundation secures $50M worth of SOL at a 15% discount , lowering entry cost. Sharps stock nearly doubled intraday , before closing +62% on the day. Bold takeaway: A small-cap healthcare firm is trying to reinvent itself as a Solana treasury powerhouse. 🗞 Main Story Sharps Technology, known for designing specialized syringe systems , shocked markets with a radical pivot: a $400M private placement (PIPE) designed to build the largest corporate Solana treasury to date . PIPE details: Units priced at $6.50/share with accompanying warrants at $...